New Zealand's Pharmac funds CGMs and insulin pumps for type 1 diabetes patients from July.

New Zealand's Pharmac announces from July, continuous glucose monitors (CGMs) and insulin pumps will be fully funded for type 1 diabetes patients, transforming their lives and managing glucose levels more effectively. The cost barrier has previously limited access, but this new funding will help close the gap. Diabetes services will also work on expanding their workforce to maximize benefits of the technology. A public consultation will be held for one month for feedback on funding options.

May 21, 2024
4 Articles